fda approval in rcc, european approvals in myeloma and melanoma, and 2016 aua highlights
Published 8 years ago • 102 plays • Length 8:00
Download video MP4
Download video MP3
Similar videos
-
10:23
fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
-
9:24
fda approvals in myeloma and head and neck cancer, and findings across several tumor types
-
10:55
fda approval in myeloma, label update in her2 breast cancer, and more
-
7:49
fda approval sought in multiple myeloma, 2017 aacr annual meeting highlights, and more
-
1:34
dr. anderson on recent fda approvals in multiple myeloma
-
10:20
fda approvals in myeloma and thyroid cancer, priority review and nda in nsclc, and more
-
9:17
fda approvals in cscc, nsclc, and myeloma, breakthrough designation in prostate cancer, and more
-
1:05
covalent-101: bmf-219 in patients with r/r aml, dlbcl & multiple myeloma
-
1:31
roger pearse, m.d., ph.d.
-
6:56
fda approves tas-102, nivolumab breakthrough in rcc, two priority reviews, and more
-
12:53
fda approval in sclc, partial hold in myeloma trials, nccn guideline update in crc, and more
-
4:35
molecular profiling for myeloma and its precursor disease
-
9:02
fda approval in sarcoma, priority reviews in mcrpc and myeloma, and more
-
1:00
the recent fda approval of teclistamab for r/r multiple myeloma
-
0:24
investigational cancer compound approved for human trials
-
2:36
kidney cancer research: fda approves immunotherapy combination
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
1:55
what is the most common cause of renal failure in newly diagnosed patients with multiple myeloma?
-
4:19
what standard testing follows a myeloma diagnosis?
Clip.africa.com - Privacy-policy